Coave Therapeutics

Coave Therapeutics develops innovative gene therapy products for rare ophthalmic diseases to preserve visual autonomy in affected patients.

Industries

Headquarters

Paris, France

Employees

11-50

Links

Org chart

Rodolphe Clerval
CEO & Director
Collapse
Thomas Blaettler
Chief Medical Officer
Catherine Mathis
Chief Development Officer
Claudia Mitchell
Interim Chief Scientific Officer
Julien Berger
VP, Legal Affairs & Corporate Secretary
Michael Hocquemiller
VP, Translational Sciences
Gaelle Lefevre
Head, Discovery Sciences
Cédric Cousteix
Finance Director
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.